1. Home
  2. POST vs ELVN Comparison

POST vs ELVN Comparison

Compare POST & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Post Holdings Inc.

POST

Post Holdings Inc.

HOLD

Current Price

$84.42

Market Cap

5.0B

ML Signal

HOLD

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

HOLD

Current Price

$59.32

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POST
ELVN
Founded
1895
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
4.2B
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
POST
ELVN
Price
$84.42
$59.32
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$124.50
$43.40
AVG Volume (30 Days)
1.0M
772.4K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.17
EPS
4.59
N/A
Revenue
$8,158,100,000.00
N/A
Revenue This Year
$4.93
N/A
Revenue Next Year
$0.47
N/A
P/E Ratio
$18.27
N/A
Revenue Growth
2.97
N/A
52 Week Low
$75.40
$14.79
52 Week High
$116.35
$62.32

Technical Indicators

Market Signals
Indicator
POST
ELVN
Relative Strength Index (RSI) 50.25 57.30
Support Level $76.27 $56.69
Resistance Level $93.96 $62.16
Average True Range (ATR) 2.44 2.05
MACD 0.72 -0.47
Stochastic Oscillator 72.60 55.73

Price Performance

Historical Comparison
POST
ELVN

About POST Post Holdings Inc.

Post Holdings Inc. is a consumer packaged goods holding company with products sold through grocery, club, and drug stores, mass merchandisers, foodservice, food ingredient, and eCommerce. It operates through four reportable segments: Post Consumer Brands, focused on North American ready-to-eat cereal and granola, pet food, and nut butters; Weetabix, focused on U.K. ready-to-eat cereal, muesli, and protein-based shakes; Foodservice, focused on egg and potato products; and Refrigerated Retail, focused on side dish, egg, cheese, and sausage products. Products are sold across channels, including retailers, wholesalers, convenience stores, pet supply retailers, drug store customers, military and national restaurant chains, with revenues largely generated in the U.S.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Share on Social Networks: